Effectiveness of Spacer Devices on Preventing Undesirable Cardiovascular Effects of Inhaled Salbutamol.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of aerosol medicine and pulmonary drug delivery"
DOI: 10.1089/jamp.2019.1591
Abstract: Background: Currently, there are no regulatory guidelines indicating spacer devices/valved holding chamber (VHC) should be used routinely during pulmonary function tests, and few studies evaluated if spacer devices reduce beta-agonist bronchodilators' side effects. Methods: A… read more here.
Keywords: beta agonist; spacer; spacer devices; agonist bronchodilators ... See more keywords